Australia, July 9 -- Cerecin Inc., owns the trademark (2540493) for 'REFYME' till March 14, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment and prevention of memory disorders, cognition disorders, neurological disorders, neurodegenerative disorders, dementia and Alzheimer's disease; pharmaceutical preparations in the nature of a neuroprotective agent.]
Type of Mark: Word
Date of Acceptance: May 1
Registration Advertised: July 8
For further details contact Felicia J. Boyd Norton Rose Fulbright US LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2540493.
Disclaimer: Curated by HT Syndication....